Sunday, September 14, 2014

Hot Electric Utility Companies To Watch For 2014

Popular Posts: 3 Game-Changing Tech Stocks to Put On Your Radar ScreenCandy Crush is Fun, But KING Investors Should Play ElsewhereNew Biotech Breakthrough: Buy Intermune Stock Recent Posts: New Biotech Breakthrough: Buy Intermune Stock Candy Crush is Fun, But KING Investors Should Play Elsewhere 3 Game-Changing Tech Stocks to Put On Your Radar Screen View All Posts

The market continues to face resistance, due in part to the lingering unease in Ukraine and the possible delay or interruption of energy supplies in the region, and the disappointing economic data out of China. Those are tough overhangs to battle, and resulting profit-taking has sent stocks lower. We talked about the latest geopolitical issues and our exposure to them in last week’s update.

Hot Blue Chip Companies For 2015: Insulet Corporation(PODD)

Insulet Corporation, a medical device company, engages in the development, manufacture, and marketing of insulin infusion systems for people with insulin-dependent diabetes in the United States. The company offers OmniPod Insulin Management System (OmniPod System), which consists of the OmniPod disposable insulin infusion device and the handheld wireless personal diabetes manager to provide diabetes management solution for people with insulin-dependent diabetes. It is also involved in the distribution of durable medical equipment, including blood glucose testing supplies, insulin pumps, pump supplies, pharmaceuticals, and other products for the management and treatment of diabetes. The company sells its OmniPod System directly to patients through referrals from healthcare professionals and through patient leads, as well as through third-party distributors; and delivers durable medical equipment to endocrinologists, insurers, and clients. Insulet Corporation was founded in 2000 and is headquartered in Bedford, Massachusetts.

Advisors' Opinion:
  • [By James Brumley]

    And just for the record, theme-based buyout speculation doesn’t improve your chances of picking an acquisition target. Back in 2012 after Bristol-Myers Squibb (BMY) bought Amylin for control of its diabetes pipeline following the purchase of Neighborhood Diabetes by Insulet (PODD), pundits were sure it would spark a wave of other diabetes-driven acquisitions. Those other M&A candidates began getting bid up, but as it turns out, no more meaningful buyouts materialized in the diabetes space.

  • [By Rich Smith]

    This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines feature a pair of downgrades for document storage company Iron Mountain (NYSE: IRM  ) and insulin treatments-equipment maker Insulet (NASDAQ: PODD  ) . But the headlines aren't all bad, so before we break the bad news to you, let's start off on a bright note about...

Hot Electric Utility Companies To Watch For 2014: Dyax Corp.(DYAX)

Dyax Corp., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel biotherapeutics for unmet medical needs in the United States. The company utilizes its proprietary drug discovery technology, known as phage display, to identify antibody, small protein, and peptide compounds. It markets KALBITOR (ecallantide) for the treatment of acute attacks of hereditary angioedema (HAE) in patients 16 years of age and older. Dyax Corp. also provides KALBITOR Access program, which offers treatment support service for patients with HAE and their healthcare providers. In addition, the company is developing a pipeline of 17 product candidates, including 4 product candidates in Phase III clinical trial, 4 product candidates in Phase II clinical trial, and 9 product candidates in Phase 1 clinical trial for the treatment of atherosclerosis, multiple sclerosis, and oncology diseases. Further, it provides library licenses to use its phage display libr aries in connection with their internal therapeutic development programs; performs funded research for various collaborators; and offers patent licenses to other biopharmaceutical and pharmaceutical companies to use its phage display patents to discover and develop biologic compounds for use in specified fields. The company has strategic partnership agreement with Defiante Farmaceutica S.A. to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other therapeutic indications in Europe, North Africa, the Middle East, and Russia; an agreement with CMIC Co., Ltd to develop and commercialize subcutaneous ecallantide for the treatment of HAE and other angioedema indications in Japan; and an license and collaboration agreement with Cubist Pharmaceuticals, Inc. to develop and commercialize the formulation of ecallantide for the reduction of blood loss during surgery in North America and Europe. Dyax Corp. was founded in 1989 and is headquartered in Cambri dge, Massachusetts.

Advisors' Opinion:
  • [By Jake L'Ecuyer]

    Dyax (NASDAQ: DYAX) shares tumbled 10.39 percent to $9.10 after the company priced 8 million shares at $9.25 per share.

    Raptor Pharmaceuticals (NASDAQ: RPTP) was down, falling 10.04 percent to $13.31 after the company reported Q4 results. Raptor Pharmaceutical posted a Q4 loss of $0.20 per share, versus the projected loss of $0.16 per share.

Hot Electric Utility Companies To Watch For 2014: iShares MSCI Ireland Capped ETF (EIRL)

iShares MSCI Ireland Capped ETF, formerly iShares MSCI Ireland Capped Investable Market Index Fund (the Fund), seeks investment results that correspond generally to the price and yield performance of the MSCI Ireland Investable Market 25/50 Index (the Index). The Index is a free-float adjusted market capitalization-weighted index designed to measure the performance of equity securities in the top 99% by market capitalization of equity securities listed on the stock exchanges in Ireland. BlackRock Fund Advisors (BFA) serves as the investment advisor of the Fund. BFA is a subsidiary of BlackRock Institutional Trust Company, N.A. Advisors' Opinion:
  • [By Charles Sizemore]

    How does an investment manager reconcile all of the various prognostications he hears on a daily basis?Simple��gnore them.��eb Faber, Global ValueIf you��e never heard of Cambria Investment Management�� Meb Faber, then you have some serious catching up to do. I consider Faber one of the most innovative strategists in the business today, and I found his research on shareholder yield to be compelling enough to make the Cambria Shareholder Yield ETF (SYLD) a core, long-term holding in multiple ETF portfolios I manage. (For readers unfamiliar with the term, ��hareholder yield��is a holistic measure of shareholder friendliness that includes dividends paid, shares repurchased, and debt repaid.)Faber�� latest book, Global Value: How to Spot Bubbles, Avoid Market Crashes, and Earn Big Returns in the Stock Market, provides the research underpinnings for Cambria�� latest ETF offering, the Cambria Global Value ETF (GVAL).Faber is a ��uant��who ignores the news of the day and instead focuses on the raw numbers. At its core, Global Value is a roadmap for implementing the value investing concepts originally espoused by Benjamin Graham and David Dodd in their 1934 classic Security Analysis in a systematic, quantitative manner.Specifically, Faber uses the cyclically-adjusted price/earnings ratio (��APE��, a metric popularized by Yale economist Robert Shiller, as a valuation tool to rank countries. In Faber�� model, an investor buys the stocks of the cheapest countries as ranked by the CAPE.The CAPE divides the current market price by the average of annual earnings across the economic cycle, with 10 years being the most popular time interval.Why? Because using a single year�� earnings can massively skew the results based on where you are in the economic cycle. As an example, a collapse in earnings in 2008-2009 would have made the S&P 500 look expensive had you used a simple P/E calculation with 2008 earnings numbers, even though the market had los

Hot Electric Utility Companies To Watch For 2014: Gafisa SA (GFA)

Gafisa S.A. (Gafisa), incorporated on November 12, 1996, is a diversified national homebuilder serving all demographic segments of the Brazilian market. The Company�� brands include Tenda, which serves the affordable entry-level housing segments, Gafisa, which offers a variety of residential options to the mid to higher income segments and Alphaville, which focuses on the identification, development and sale of residential communities. In addition, it provides construction services to third parties. Gafisa�� core business is the development of residential units in attractive locations. During the year ended December 31, 2009, approximately 55% of the value of its launches was derived from high and mid high-level residential developments under the Gafisa brand. It is also engaged in the development of land subdivisions, also known as residential communities, representing approximately 18% of the value of its launches under the Alphaville brand, and affordable entry-level housing, which represents approximately 27% of the value of its launches under the Tenda brand. In addition, it provides construction services to third parties. Gafisa operates in more than 120 cities, including Sao Paulo, Rio de Janeiro, Salvador, Fortaleza, Natal, Curitiba, Belo Horizonte, Manaus, Porto Alegre and Belem, across 21 states and the Federal District.

Real Estate Activities

The Company�� real estate business includes developments for sale of residential units; land subdivisions (also known as residential communities); commercial buildings; construction services to third parties, and sale of units through its brokerage subsidiaries, Gafisa Vendas and Gafisa Vendas Rio, jointly referred to as Gafisa Vendas. In the residential buildings product category, Gafisa develops three main types of products: luxury buildings targeted at upper-income customers, buildings targeted at middle-income customers; and affordable entry-level housing targeted at lower-income customers. Quality residential buildi! ngs for middle- and upper-income customers are its core products. Luxury buildings units usually have over 180 square meters of private area, at least four bedrooms and three parking spaces. The development includes swimming pools, gyms, visitor parking, and other amenities.

Buildings targeted at middle-income customers have accounted for the majority of its sales. Units usually have between 90 and 180 square meters of private area, three or four bedrooms and two to three underground parking spaces. Buildings are usually developed in large tracts of land as part of multi-building developments and, to a lesser extent, in smaller lots in attractive neighborhoods. Affordable entry-level housing consists of building and house units. Units usually have between 42 to 60 square meters of indoor private area and two to three bedrooms.

Commercial Buildings

During 2009, the Company launched four commercial buildings. These buildings include Centro Empresarial Madureira, Paulista Corporate, Reserva Eco Office Life and Global Offices.

Construction Service

Gafisa provide construction services to third parties, building residential and commercial projects for developers in Brazil. The Company�� principal construction services clients are large companies, many of them developers that do not build their own projects. As of December 31, 2009, its principal construction services clients were Fibra Empreendimentos Imobiliarios S.A., Sisan-Grupo Silvio Santos, Camargo Correa Desenvolvimento Imobiliario S.A., Helbor Empreendimentos Imobiliarios Ltda., InCons S.A., SDI Desenvolvimento Imobiliario Ltda. and Abyara. It also provides construction services on certain developments where it retains an equity interest.

Advisors' Opinion:
  • [By Jon C. Ogg]

    Gafisa S.A. (NYSE: GFA) is a homebuilder in Brazil, supposedly with more than $1 billion in projects for 2014 alone. This ADR trades at $3.05 against a 52-week range of $2.22 to $5.24, and this is down only about 2% so far in 2014.

  • [By Roberto Pedone]

    Gafisa (GFA) is a homebuilder in Brazil. This stock closed up 5% to $3.13 in Tuesday's trading session.

    Tuesday's Range: $2.97-$3.15

    52-Week Range: $2.22-$5.24

    Tuesday's Volume: 1.70 million

    Three-Month Average Volume: 1.77 million

    From a technical perspective, GFA ripped higher here right above some near-term support at $2.80 with decent upside volume. This stock has been uptrending strong for the last month, with shares moving higher from its low of $2.27 to its intraday high of $3.15. During that move, shares of GFA have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of GFA within range of triggering a big breakout trade. That trade will hit if GFA manages to take out Tuesday's high of $3.15 to some past resistance at $3.30 with high volume.

    Traders should now look for long-biased trades in GFA as long as it's trending above support at $2.80 and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.77 million shares. If that breakout triggers soon, then GFA will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day moving average of $3.68 to more resistance at $4.20 to $4.70.

Hot Electric Utility Companies To Watch For 2014: Amerco (UHAL)

AMERCO, through its subsidiary U-Haul International, Inc., a do-it-yourself moving and storage operator that supplies products and services to help people move and store their household and commercial goods in the United States and Canada. The company engages in the rental of trucks, trailers, specialty rental items, and self-storage spaces primarily to the household mover as well as sales of moving supplies, towing accessories and propane. It also offers eMove, an online marketplace, which connects consumers to independent moving help service providers and independent self-storage affiliates, as well as manages self-storage properties. In addition, the company provides loss adjusting and claims handling services, as well as underwrites moving and storage protection packages, including Safemove and Safetow that provide moving and towing customers with a damage waiver, cargo protection, and medical and life insurance coverage; Safestor, which protects storage customers from loss on their goods in storage; and Super Safemove that offer rental customer with a layer of primary liability protection. Further, it provides life and health insurance products primarily to the senior market through the direct writing or reinsuring of life insurance, medicare supplement, and annuity policies. The company rents its orange and white U-Haul trucks and trailers, as well as offers self-storage rooms through a network of approximately 1,400 company operated retail moving centers and approximately 15,000 independent U-Haul dealers. Its rental fleet consists of approximately 101,000 trucks, 82,000 trailers, and 33,000 towing devices, as well as operates approximately 1,115 self-storage locations in North America, with approximately 411,000 rentable rooms. The company was founded in 1945 and is based in Reno, Nevada.

Advisors' Opinion:
  • [By Rich Smith]

    Given my druthers, were I asked to recommend a truck rental shop today, I think I'd have to go with U-Haul owner AMERCO (NASDAQ: UHAL  ) instead. It's got the free cash flow that Ryder lacks, plus a cheaper P/E, a slightly faster growth rate, and a smaller debt load. Honestly, I don't "love" AMERCO either -- but it's a heck of a better value than Ryder.

No comments:

Post a Comment